Quarterly report pursuant to Section 13 or 15(d)

Shareholders??? Equity (Details) - Schedule of Share Options, Granted to Employees, Directors, Under Option Plans

v3.24.2.u1
Shareholders’ Equity (Details) - Schedule of Share Options, Granted to Employees, Directors, Under Option Plans
6 Months Ended
Dec. 31, 2023
$ / shares
shares
Jun. 30, 2024
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Outstanding balance | shares 87,764 65,102
Weighted- Average Exercise Price, Outstanding balance | $ / shares $ 3.63 $ 4.39
Weighted Average Remaining Contractual Life, Outstanding balance 4 years 1 month 9 days 3 years 7 months 6 days
Number of Options, Exercisable | shares   58,818
Weighted- Average Exercise Price, Exercisable | $ / shares   $ 3.11
Weighted Average Remaining Contractual Life, Exercisable   3 years 2 months 12 days
Number of Options, Granted | shares  
Weighted- Average Exercise Price, Granted | $ / shares  
Number of Options, Exercised | shares   (21,225)
Weighted- Average Exercise Price, Exercised | $ / shares   $ 3.37
Number of Options, Forfeited | shares   (1,362)
Weighted- Average Exercise Price, Forfeited | $ / shares   $ 4.73